Fresh Tracks Therapeutics Valuation

Fresh Tracks Investor Information

The company has price-to-book (P/B) ratio of 0.45. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresh Tracks Therapeutics recorded a loss per share of 2.32. The entity last dividend was issued on the 3rd of September 2019. The firm had 1:45 split on the 5th of July 2022. Based on the key indicators related to Fresh Tracks' liquidity, profitability, solvency, and operating efficiency, Fresh Tracks Therapeutics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Fresh Tracks Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fresh Tracks has an asset utilization ratio of 67.6 percent. This suggests that the Company is making $0.68 for each dollar of assets. An increasing asset utilization means that Fresh Tracks Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.

Fresh Tracks Ownership Allocation

Fresh Tracks Therapeutics shows 11.62 percent of its outstanding shares held by insiders and 8.96 percent owned by other corporate entities.

Fresh Tracks Profitability Analysis

The company reported the previous year's revenue of 6.94 M. Net Loss for the year was (21.1 M) with loss before overhead, payroll, taxes, and interest of (27.83 M).

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.